Evidence map›Paper›PMID 22645291›Full record

ArticleCirculation2012

Genetics and cardiovascular disease: a policy statement from the American Heart Association.

Euan A Ashley, Ray E Hershberger, Colleen Caleshu, Patrick T Ellinor, Joe G N Garcia, David M Herrington, Carolyn Y Ho, Julie A Johnson, Steven J Kittner, Calum A Macrae and 9 more

Abstract read
In one paragraph

Article in Circulation, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. The emerging role of sorting nexins in cardiovascular diseases.Clinical science (London, England : 1979) · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Genes and Cardiovascular Disease: Where do we go from here?Sultan Qaboos University medical journal · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Euan A Ashley
Ray E Hershberger
Colleen Caleshu
Patrick T Ellinor
Joe G N Garcia
David M Herrington
Carolyn Y Ho
Julie A Johnson
Steven J Kittner
Calum A Macrae
Gia Mudd-Martin
Daniel J Rader
Dan M Roden
Derek Scholes
Frank W Sellke
Jeffrey A Towbin
Jennifer Van Eyk
Bradford B Worrall
American Heart Association Advocacy Coordinating Committee

Funding

Pharmacogenomic Evaluation of Antihypertensive ResponsesU01GM074492 · NIGMS · UNIVERSITY OF FLORIDA · PI COOPER-DEHOFF, RHONDA M, JOHNSON, JULIE A. · 2005 to 2014
$20.7M
NIGMS NIH HHS U01 GM074492
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

American Heart AssociationPolicy MakingCardiovascular DiseasesGenetic TestingHumansPharmacogeneticsUnited States

Identifiers

PMID22645291
PMCPMC3721666

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.